Glepaglutide 20.0 mg/mL, Glepaglutide Placebo clinical trials

A DOUBLE-BLIND PHASE 3 EXTENSION TRIAL ASSESSING THE LONG TERM SAFETY AND EFFICACY OF GLEPAGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME (SBS)

This study is looking at a new medicine called glepaglutide for people with Short Bowel Syndrome. It wants to see how safe and effective it is over a long time. Researchers will compare glepaglutide to a dummy medicine to see if it helps reduce the need for intravenous feeding.